<DOC>
	<DOCNO>NCT01785160</DOCNO>
	<brief_summary>The primary objective trial investigate effect faldaprevir steady state pharmacokinetics raltegravir . The assessment safety tolerability additional objective trial .</brief_summary>
	<brief_title>Investigation Faldaprevir Effect Pharmacokinetics Raltegravir</brief_title>
	<detailed_description />
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Inclusion criterion : 1. healthy male subject Exclusion criterion : 1 . Any relevant deviation healthy condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>